- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- BMA: beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x DNQ: 6,7-DINITROQUINOXALINE-2,3-DIONE(Non-covalent)
DNQ.7: 10 residues within 4Å:- Chain A: E.440, Y.488, P.516, L.517, A.518, R.523, N.721, E.738, T.741, Y.764
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:E.440, A:A.518, A:R.523, A:R.523, A:E.738
- pi-Stacking: A:Y.488, A:Y.488
DNQ.21: 9 residues within 4Å:- Chain B: E.440, Y.488, P.516, L.517, A.518, R.523, N.721, T.741, Y.764
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:E.440, B:A.518, B:R.523, B:R.523
- pi-Stacking: B:Y.488
DNQ.27: 9 residues within 4Å:- Chain C: E.440, Y.488, P.516, L.517, A.518, R.523, N.721, E.738, Y.764
7 PLIP interactions:7 interactions with chain C- Hydrogen bonds: C:E.440, C:A.518, C:R.523, C:R.523, C:E.738
- pi-Stacking: C:Y.488, C:Y.488
DNQ.40: 9 residues within 4Å:- Chain D: E.440, Y.488, P.516, L.517, A.518, R.523, N.721, T.741, Y.764
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:E.440, D:A.518, D:R.523, D:R.523
- pi-Stacking: D:Y.488
- 16 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.8: 20 residues within 4Å:- Chain A: P.550, G.551, F.553, L.556, N.557, W.564, L.568, C.571, L.572, F.612, V.616, L.619, M.620, I.647, I.648, Y.651, V.826
- Chain D: F.642
- Ligands: POV.9, POV.11
Ligand excluded by PLIPPOV.9: 11 residues within 4Å:- Chain A: F.553, L.568, W.613, V.616, I.825, A.829, L.833
- Chain D: I.635, I.639
- Ligands: POV.8, POV.11
Ligand excluded by PLIPPOV.10: 14 residues within 4Å:- Chain A: V.552, V.817, Q.818, G.821, F.824, I.825, A.828, A.829, L.831, V.832, L.833, V.835
- Chain D: Y.566, A.570
Ligand excluded by PLIPPOV.11: 10 residues within 4Å:- Chain A: L.608, L.609, F.612, L.833, F.836, V.837, G.840, Y.844
- Ligands: POV.8, POV.9
Ligand excluded by PLIPPOV.13: 13 residues within 4Å:- Chain A: R.634, I.635, I.639
- Chain B: F.553, L.568, L.609, V.616, A.829, G.830, L.833
- Ligands: POV.14, POV.22, POV.23
Ligand excluded by PLIPPOV.14: 13 residues within 4Å:- Chain A: Y.587, L.631
- Chain B: C.571, L.572, L.608, F.612, V.616, L.833, F.836, G.840, E.841
- Ligands: POV.13, POV.22
Ligand excluded by PLIPPOV.22: 22 residues within 4Å:- Chain A: G.638, I.639, F.642, L.645
- Chain B: P.550, G.551, V.552, F.553, L.556, P.561, W.564, M.565, L.568, V.616, L.619, M.620, I.647, I.648, Y.651, V.826
- Ligands: POV.13, POV.14
Ligand excluded by PLIPPOV.23: 14 residues within 4Å:- Chain A: Y.566
- Chain B: V.552, V.817, Q.818, G.821, F.824, I.825, L.827, A.828, A.829, L.831, V.832, V.835
- Ligands: POV.13
Ligand excluded by PLIPPOV.28: 20 residues within 4Å:- Chain B: I.639, F.642
- Chain C: P.550, G.551, F.553, L.556, W.564, V.567, L.568, L.572, F.612, V.616, L.619, M.620, I.647, I.648, Y.651, V.826
- Ligands: POV.29, POV.31
Ligand excluded by PLIPPOV.29: 13 residues within 4Å:- Chain B: L.631, R.634, I.635, I.639
- Chain C: F.553, L.568, W.613, V.616, I.825, A.829, L.833
- Ligands: POV.28, POV.31
Ligand excluded by PLIPPOV.30: 13 residues within 4Å:- Chain B: Y.566
- Chain C: V.552, V.817, Q.818, G.821, F.824, I.825, A.828, A.829, L.831, V.832, L.833, F.836
Ligand excluded by PLIPPOV.31: 12 residues within 4Å:- Chain B: Y.587
- Chain C: L.608, L.609, F.612, L.833, F.836, V.837, G.840, E.841, Y.844
- Ligands: POV.28, POV.29
Ligand excluded by PLIPPOV.33: 23 residues within 4Å:- Chain C: G.638, I.639, F.642, L.645
- Chain D: P.550, G.551, V.552, F.553, S.554, L.556, P.561, W.564, M.565, L.568, V.616, L.619, M.620, I.647, I.648, Y.651, V.826
- Ligands: POV.34, POV.35
Ligand excluded by PLIPPOV.34: 15 residues within 4Å:- Chain C: R.634, I.635, G.638, I.639
- Chain D: F.553, L.568, L.609, W.613, V.616, V.826, A.829, G.830
- Ligands: POV.33, POV.35, POV.41
Ligand excluded by PLIPPOV.35: 14 residues within 4Å:- Chain C: Y.587, L.631
- Chain D: C.571, L.572, L.608, L.609, F.612, V.616, L.833, F.836, G.840, E.841
- Ligands: POV.33, POV.34
Ligand excluded by PLIPPOV.41: 12 residues within 4Å:- Chain C: Y.566
- Chain D: V.552, V.817, Q.818, G.821, F.824, I.825, A.828, A.829, L.831, V.832
- Ligands: POV.34
Ligand excluded by PLIP- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x NA: SODIUM ION(Non-functional Binders)
NA.15: 4 residues within 4Å:- Chain A: T.652
- Chain B: T.652
- Chain C: T.652
- Chain D: T.652
No protein-ligand interaction detected (PLIP)NA.16: 0 residues within 4Å:- (No contacts)
1 PLIP interactions:1 interactions with chain B- Water bridges: B:Q.621
NA.17: 3 residues within 4Å:- Chain B: A.656
- Chain C: T.660
- Chain D: A.656
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:A.656
NA.18: 3 residues within 4Å:- Chain A: E.524, I.527, D.528
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.528, A:R.775
NA.25: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)NA.26: 4 residues within 4Å:- Chain B: E.524, D.528, M.770
- Chain C: I.780
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.524, B:D.528
NA.36: 3 residues within 4Å:- Chain C: E.524, I.527, D.528
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:I.527, C:R.775
NA.42: 4 residues within 4Å:- Chain A: I.780
- Chain D: E.524, D.528, M.770
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:E.524, D:D.528
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x 2J9: 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide(Non-covalent)
2J9.20: 13 residues within 4Å:- Chain B: K.531, P.532, F.533, T.535, L.783, Q.786
- Chain C: I.519, P.532, M.534, T.535, S.761, K.762, G.763
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:P.532
- Halogen bonds: C:M.534
2J9.24: 15 residues within 4Å:- Chain B: I.519, P.532, M.534, T.535, S.761, K.762, G.763
- Chain C: K.531, P.532, F.533, M.534, T.535, L.783, Q.786, L.791
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:P.532, C:T.535, C:L.791
- Halogen bonds: B:M.534
2J9.38: 14 residues within 4Å:- Chain A: K.531, P.532, F.533, T.535, L.783, Q.786, L.791
- Chain D: I.519, P.532, M.534, T.535, S.761, K.762, G.763
4 PLIP interactions:2 interactions with chain D, 2 interactions with chain A- Hydrophobic interactions: D:P.532, A:T.535, A:L.791
- Halogen bonds: D:M.534
2J9.39: 13 residues within 4Å:- Chain A: I.519, P.532, M.534, T.535, S.761, K.762, G.763
- Chain D: K.531, P.532, F.533, T.535, L.783, Q.786
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:P.532
- Halogen bonds: A:M.534
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gangwar, S.P. et al., Positive and negative allosteric modulation of GluK2 kainate receptors by BPAM344 and antiepileptic perampanel. Cell Rep (2023)
- Release Date
- 2023-04-19
- Peptides
- Glutamate receptor ionotropic, kainate 2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- BMA: beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x DNQ: 6,7-DINITROQUINOXALINE-2,3-DIONE(Non-covalent)
- 16 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x NA: SODIUM ION(Non-functional Binders)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x 2J9: 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gangwar, S.P. et al., Positive and negative allosteric modulation of GluK2 kainate receptors by BPAM344 and antiepileptic perampanel. Cell Rep (2023)
- Release Date
- 2023-04-19
- Peptides
- Glutamate receptor ionotropic, kainate 2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.